Form 8-K GALECTIN THERAPEUTICS For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Galectin Therapeutics (GALT) Misses Q1 EPS by 2c
May 11, 2015 8:07 AM EDTGalectin Therapeutics (NASDAQ: GALT) reported Q1 EPS of ($0.22), $0.02 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.
... More


